However, recent studies showed that DYRK1B expression was elevated in quiescent pancreatic cancer cells, and overexpression of DYRK1B induced the G1/S phase arrest via phosphorylation at Thr286 and proteasome-dependent turnover of Cyclin D131,32. The gene discussed is DYRK1B; the disease is pancreatic neoplasm.